Robert Duggan, Chairman & CEO, Director, Ten Percent Owner at Pharmacyclics, holds 37.83M shares in Pulse Biosciences (Ticker: PLSE), holds 552.35M shares in Summit Therapeutics (Ticker: SMMT), holds 5.76M shares in Achaogen (Ticker: AKAOQ). Most recently, Robert Duggan Bought ― shares of Pulse Biosciences on Dec 14, 2023 for an estimated value of 164.69K.